Skip to main content
SpringerLink
Log in

Acne inversa (Hidradenitis suppurativa)

Erkennen – Verstehen – Therapieren

Acne inversa (hidradenitis suppurativa)

From diagnosis to therapy

  • CME Zertifizierte Fortbildung
  • Published:
Der Hautarzt Aims and scope Submit manuscript

Zusammenfassung

Schätzungsweise 1% der Bevölkerung leidet an Hidradenitis suppurativa/Acne inversa, einer chronisch entzündlichen Erkrankung, die Patienten und Ärzte vor große Herausforderungen stellt. Die progrediente Erkrankung isoliert die Patienten zunehmend sozial und bereitet konstante Schmerzen. Oftmals vergehen Jahre bis zur korrekten Diagnosestellung. Die behandelnden Hautärzte werden mit einem rezidivierenden Krankheitsbild und oftmals frustrierten Patienten konfrontiert. Der Beitrag vermittelt Basiswissen und ordnet Therapiemöglichkeiten.

Abstract

An estimated 1% of the population suffers from hidradenitis suppurativa/acne inversa, a chronic inflammatory disease that is a burden for patients and doctors alike. The progressive disease often isolates the patients socially and causes constant pain. It can take years until the diagnosis is finally made. Dermatologists are often confronted with a relapsing condition and a frustrated patient. This article summarizes our understanding of the disease and outlines therapeutic options.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Plewig G, Steger M (1989) Acne inversa. In: Marks R, Plewig G (Hrsg) Acne and related disorders. Dunitz, London, S 345–347

  2. Kamp S, Fiehn AM, Stenderup K et al (2011) Hidradenitis suppurativa: a disease of the absent sebaceous gland? Sebaceous gland number and volume are significantly reduced in uninvolved hair follicles from patients with hidradenitis suppurativa. Br J Dermatol 164:1017–1022

    Article  PubMed  CAS  Google Scholar 

  3. Revuz JE, Canoui-Poitrine F, Wolkenstein P et al (2008) Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J Am Acad Dermatol 59:596–601

    Article  PubMed  Google Scholar 

  4. Vazquez BG, Alikhan A, Weaver AL et al (2012) Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, Minnesota. J Invest Dermatol doi:10.1038/jid.2012.255 [Epub ahead of print]

    Google Scholar 

  5. Sabat R, Chanwangpong A, Schneider-Burrus S et al (2012) Increased prevalence of metabolic syndrome in patients with acne inversa. PLoS One 7:e31810

    Article  PubMed  CAS  Google Scholar 

  6. Nazary M, Zee HH van der, Prens EP et al (2011) Pathogenesis and pharmacotherapy of hidradenitis suppurativa. Eur J Pharmacol 672:1–8

    Article  PubMed  CAS  Google Scholar 

  7. Jemec GB, Wendelboe P (1998) Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J Am Acad Dermatol 39:971–974

    Article  PubMed  CAS  Google Scholar 

  8. Sartorius K, Killasli H, Oprica C et al (2012) Bacteriology of hidradenitis suppurativa exacerbations and deep tissue cultures obtained during carbon dioxide laser treatment. Br J Dermatol 166:879–883

    Article  PubMed  CAS  Google Scholar 

  9. Revuz J (2010) Hidradenitis suppurativa. Presse Med 39:1254–1264

    Article  PubMed  Google Scholar 

  10. Pink AE, Simpson MA, Brice GW et al (2011) PSENEN and NCSTN mutations in familial hidradenitis suppurativa (Acne Inversa). J Invest Dermatol 131:1568–1570

    Article  PubMed  CAS  Google Scholar 

  11. Li T, Wen H, Brayton C et al (2007) Epidermal growth factor receptor and notch pathways participate in the tumor suppressor function of gamma-secretase. J Biol Chem 282:32264–32273

    Article  PubMed  CAS  Google Scholar 

  12. Hurley HJ (1989) Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa, and familial benign pemphigus: surgical approach. In: Roenigh RK, Roenigh HH (Hrsg) Dermatologic surgery. Marcel Dekker, New York, S 729–739

  13. Sartorius K, Lapins J, Emtestam L, Jemec GB (2003) Suggestions for uniform outcome variables when reporting treatment effects in hidradenitis suppurativa. Br J Dermatol 149:211–213

    Article  PubMed  CAS  Google Scholar 

  14. Maclean GM, Coleman DJ (2007) Three fatal cases of squamous cell carcinoma arising in chronic perineal hidradenitis suppurativa. Ann R Coll Surg Engl 89:709–712

    Article  PubMed  Google Scholar 

  15. Mortimer PS, Dawber RP, Gales MA, Moore RA (1986) A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa. Br J Dermatol 115:263–268

    Article  PubMed  CAS  Google Scholar 

  16. Mendonça CO, Griffiths CE (2006) Clindamycin and rifampicin combination therapy for hidradenitis suppurativa. Br J Dermatol 154:977–978

    Article  PubMed  Google Scholar 

  17. Gener G, Canoui-Poitrine F, Revuz JE et al (2009) Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients. Dermatology 219:148–154

    Article  PubMed  CAS  Google Scholar 

  18. Boer J, Nazary M (2011) Long-term results of acitretin therapy for hidradenitis suppurativa. Is acne inversa also a misnomer? Br J Dermatol 164:170–175

    Article  PubMed  CAS  Google Scholar 

  19. Blok JL, Hattem S van, Jonkman MF, Horváth B (2012) Systemic therapy with immunosuppressive agents and retinoids in hidradenitis suppurativa: a systematic review. Br J Dermatol doi:10.1111/bjd.12104 [Epub ahead of print]

    Google Scholar 

  20. Rambhatla PV, Lim HW, Hamzavi I (2012) A systematic review of treatments for hidradenitis suppurativa. Arch Dermatol 148:439–446

    Article  PubMed  CAS  Google Scholar 

  21. van der Zee HH, de Ruiter L, van den Broecke DG et al (2011) Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β. Br J Dermatol 164:1292–1298

    Article  Google Scholar 

  22. Patel RV, Clark LN, Lebwohl M, Weinberg JM (2009) Treatments for psoriasis and the risk of malignancy. J Am Acad Dermatol 60:1001–1017

    Article  PubMed  Google Scholar 

  23. Tierney E, Mahmoud BH, Hexsel C et al (2009) Randomized control trial fort he treatment of hidradenitis suppurativa with a neodynium-doped yttrium aluminium garnet laser. Dermatol Surg 35:1188–1198

    Article  PubMed  CAS  Google Scholar 

  24. Mühlstädt M, Kulichová D, Kunte C (2009) Perioperative Antibiotikaprophylaxe in der Dermatochirurgie. Update 2009. Hautarzt 60:546–549

    Article  PubMed  Google Scholar 

  25. Bechara FG, Hartschuh W (2010) Acne inversa. Hautarzt 61:39–46

    Article  PubMed  CAS  Google Scholar 

  26. Ritz JP, Runkel N, Haier J, Buhr HJ (1998) Extent of surgery and recurrence rate of hidradenitis suppurativa. Int J Colorectal Dis 13:164–168

    Article  PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor weist für sich und seine Koautoren auf folgende Beziehungen hin: PD Dr. Bechara ist Studienleiter einer laufenden Phase-III-Studie zum Einsatz von Adalimumab (Abbott) bei moderater bis schwerer Hidradenitis suppurativa. PD Dr. Kunte und Dr. Mühlstädt geben an, dass kein Interessenkonflikt vorliegt.

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Dermatologie und Allergologie, Klinikum der Universität München, LMU München, Frauenlobstr. 9-11, 80337, München, Deutschland

    M. Mühlstädt & C. Kunte

  2. Ruhr-Universität Bochum, Bochum, Deutschland

    F.G. Bechara

Authors
  1. M. Mühlstädt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F.G. Bechara
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Kunte
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Mühlstädt.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mühlstädt, M., Bechara, F. & Kunte, C. Acne inversa (Hidradenitis suppurativa). Hautarzt 64, 55–62 (2013). https://doi.org/10.1007/s00105-012-2479-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00105-012-2479-8

Schlüsselwörter

Keywords

Search

Navigation